|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 5/074 | |
| G01N 33/483 | |||
| A61K 35/28 |
| (11) | Patento numeris | 2568991 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11781272.7 |
| Europos patento paraiškos padavimo data | 2011-05-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-03-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-03-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/036235 |
| Data | 2011-05-12 |
| (87) | Numeris | WO 2011/143415 |
| Data | 2011-11-17 |
| (30) | Numeris | Data | Šalis |
| 440617 P | 2011-02-08 | US | |
| 334001 P | 2010-05-12 | US |
| (72) |
MAYS, Robert, W., US
|
| (73) |
ABT Holding Company,
3201 Carnegie Avenue, Cleveland, OH 44115,
US
|
| (54) | MODULATION OF SPLENOCYTES IN CELL THERAPY |
| MODULATION OF SPLENOCYTES IN CELL THERAPY |